Your browser doesn't support javascript.
loading
Enhanced T-cell activation and differentiation in lymphocytes from transgenic mice expressing ubiquitination-resistant 2KR LAT molecules.
Rodriguez-Peña, A B; Gomez-Rodriguez, J; Kortum, R L; Palmer, D C; Yu, Z; Guittard, G C; Wohlfert, E A; Silver, P B; Misplon, J A; Sommers, C L; Feigenbaum, L; Epstein, S L; Caspi, R R; Belkaid, Y; Restifo, N P; Samelson, L E; Balagopalan, L.
Afiliación
  • Rodriguez-Peña AB; Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Gomez-Rodriguez J; Centro de Investigación del Cáncer, Salamanca, Spain.
  • Kortum RL; Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas-University of Salamanca, Salamanca, Spain.
  • Palmer DC; Cell Signaling and Immunity Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
  • Yu Z; Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Guittard GC; Department of Pharmacology; Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
  • Wohlfert EA; Tumor Immunology Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Silver PB; Tumor Immunology Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Misplon JA; Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Sommers CL; Immunity at Barrier Sites Initiative, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA.
  • Feigenbaum L; Mucosal Immunology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA.
  • Epstein SL; Department of Microbiology and Immunology, School of Medicine and Biomedical Sciences, University at Buffalo (SUNY), Buffalo, NY, USA.
  • Caspi RR; Immunoregulation Section, National Eye Institute, National Institutes of Health, Bethesda, MD, USA.
  • Belkaid Y; Center for Biologics Evaluation & Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Restifo NP; Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Samelson LE; Laboratory Animal Sciences Program, Leidos Biomedical Research Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Balagopalan L; Center for Biologics Evaluation & Research, Food and Drug Administration, Silver Spring, MD, USA.
Gene Ther ; 22(10): 781-92, 2015 Oct.
Article en En | MEDLINE | ID: mdl-26018935
ABSTRACT
Linker for activation of T cells (LAT) is critical for the propagation of T-cell signals upon T-cell receptor (TCR) activation. Previous studies demonstrated that substitution of LAT lysines with arginines (2KR LAT) resulted in decreased LAT ubiquitination and elevated T-cell signaling, indicating that LAT ubiquitination is a molecular checkpoint for attenuation of T-cell signaling. To investigate the role of LAT ubiquitination in vivo, we have generated transgenic mice expressing WT and ubiquitin-defective 2KR LAT. On TCR stimulation of T cells from these mice, proximal signaling and cytokine production was elevated in 2KR versus wild-type (WT) LAT mice. Enhanced cytolytic activity as well as T-helper responses were observed on LAT expression, which were further elevated by 2KR LAT expression. Despite greater T-effector function, WT or 2KR LAT expression did not have any effect on clearance of certain pathogens or tumors. Our data support the model that lack of tumor clearance is due to increased differentiation and acquisition of effector phenotype that is associated with suboptimal immunity in an immunotherapy model. Thus, our data further reinforce the role of LAT ubiquitination in TCR signaling and uncovers a novel role for LAT in driving T-cell differentiation.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fosfoproteínas / Activación de Linfocitos / Linfocitos / Proteínas Adaptadoras Transductoras de Señales / Proteínas de la Membrana Límite: Animals Idioma: En Revista: Gene Ther Asunto de la revista: GENETICA MEDICA / TERAPEUTICA Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fosfoproteínas / Activación de Linfocitos / Linfocitos / Proteínas Adaptadoras Transductoras de Señales / Proteínas de la Membrana Límite: Animals Idioma: En Revista: Gene Ther Asunto de la revista: GENETICA MEDICA / TERAPEUTICA Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos